Clinical/scientific notes

Neurology

Volumn 81, Issue 13, 2013, Pages 1176-1178

  Patel, Nikunj K ^a   Pavese, Nicola ^b   Javed, Shazia ^a   Hotton, Gary R ^b   Brooks, David J ^b   Gill, Steven S ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CARBIDOPA PLUS LEVODOPA; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; LEVODOPA; LISURIDE; PRAMIPEXOLE; SELEGILINE; ANTIPARKINSON AGENT; DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ABSENCE OF SIDE EFFECTS; ADULT; CASE REPORT; DAILY LIFE ACTIVITY; DRUG UPTAKE; DYSKINESIA; HUMAN; INFUSION PUMP; MALE; NOTE; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; UNIFIED PARKINSON DISEASE RATING SCALE; ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DRUG EFFECT; MIDDLE AGED; PHYSIOLOGY; SCINTISCANNING; SEVERITY OF ILLNESS INDEX; TIME;

ANTIPARKINSON AGENTS; FLUORODEOXYGLUCOSE F18; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PUTAMEN; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 84887352798     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e3182a55ea5     Document Type: Note

References (6)

1. Gill SS, Patel NK, Hotton GR, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nat Med 2003;9:589-595. (Pubitemid 36597106)
2. Patel NK, Bunnage M, Plaha P, Svendsen CN, Heywood P, Gill SS. Intraputaminal infusion of glial cell line-derived neurotrophic factor in PD: A two-year outcome study. Ann Neurol 2005;57:298-302. (Pubitemid 40179870)
3. Love S, Plaha P, Patel NK, Hotton GR, Brooks DJ, Gill SS. Glial cell line-derived neurotrophic factor induces neuronal sprouting in human brain. Nat Med 2005;11:703-704. (Pubitemid 41021193)
4. Langston JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992;7:2-13.
5. Lang AE, Gill S, Patel NK, et al. Randomized controlled trial of intraputaminal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 2006; 59:459-466. (Pubitemid 43358066)
6. Slevin JT, Gash DM, Smith CD, et al. Unilateral intraputaminal glial cell line-derived neurotrophic factor in patients with Parkinson disease: response to 1 year of treatment and 1 year of withdrawal. J Neurosurg 2007;106:614-620. (Pubitemid 46536457)